Risk-adapted Therapy for Primary Acute Myeloid Leukemia

Clinical trial NCT04687098 · COMPLETED

Trial details

NCT number: NCT04687098
Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2012-02-01
Primary completion: 2022-07-31
Enrollment: 1034

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.